Coloplast A/S, a leading global healthcare company headquartered in Denmark (DK), specialises in innovative medical devices and services for individuals with intimate healthcare needs. Founded in 1957, Coloplast has established a strong presence in Europe, North America, and Asia, focusing on areas such as ostomy care, continence care, and wound and skin care. The company is renowned for its commitment to user-friendly products, including advanced ostomy bags and continence management solutions that enhance the quality of life for patients. Coloplast's dedication to research and development has positioned it as a market leader, with notable achievements in product innovation and patient support services. With a strong emphasis on sustainability and social responsibility, Coloplast continues to make significant strides in the healthcare industry, ensuring that individuals receive the best possible care.
How does Coloplast's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Coloplast's score of 75 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Coloplast A/S reported total greenhouse gas emissions of approximately 223,305,000 kg CO2e. This includes 17,514,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 83,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. The majority of their emissions, about 205,708,000 kg CO2e, fall under Scope 3, which includes emissions from the entire value chain, such as purchased goods and services. Coloplast has set ambitious climate commitments, aiming to achieve a 100% reduction in absolute Scope 1 and 2 greenhouse gas emissions by FY2030, using FY2019 as the baseline. Additionally, they are committed to sourcing 100% renewable electricity annually through 2025. For Scope 3 emissions, the company targets a 50% reduction per product manufactured by FY2030, also from a FY2019 baseline. These targets are aligned with the Science Based Targets initiative (SBTi) and are classified as consistent with the reductions required to limit global warming to 1.5°C. Overall, Coloplast's emissions data and climate commitments reflect a strong dedication to sustainability and reducing their carbon footprint, with a focus on both operational and supply chain emissions.
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,404,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000 | - | - | 00,000,000 | 00,000,000 | 00,000 |
| Scope 3 | 9,496,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Coloplast's Scope 3 emissions, which increased by 4% last year and increased significantly since 2007, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 75% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Coloplast has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Coloplast's sustainability data and climate commitments